Beijing, China

Chunhui Qi


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Chunhui Qi

Introduction

Chunhui Qi is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmacology, particularly in the area of immune deficiency and hypoimmunity treatments. His work has the potential to impact various diseases, including hepatitis B, hepatitis C, and AIDS.

Latest Patents

Chunhui Qi holds a patent for "Polyethylene glycol modifications of thymosin alpha-1." This invention involves the preparation process of Tα1-PEGs, their medicinal composition, and their application in treating diseases related to immune deficiency. The patent addresses critical health issues, including hepatoma, malignant melanoma, non-small cell lung cancer, SARS, and AIDS.

Career Highlights

Chunhui Qi is affiliated with the Institute of Pharmacology and Toxicology at the Academy of Military Medical Sciences, P.L.A., China. His research and innovations have positioned him as a key figure in the development of new therapeutic approaches for immune-related conditions.

Collaborations

Chunhui Qi has collaborated with notable colleagues, including Keliang Liu and Jiankun Qie, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the medical field.

Conclusion

Chunhui Qi's innovative contributions to pharmacology and his patent on polyethylene glycol modifications of thymosin alpha-1 highlight his commitment to advancing medical science. His work continues to pave the way for new treatments for immune-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…